lukman-hakim
Three scientists whose work created a powerful new way to study the brain have been honoured with this year's Nobel Prize in Physiology or Medicine. US psychiatrist and neurologist Karl Deisseroth shares the award with his German colleagues Peter Hegemann and Georg Nagel. The trio received the prize for their pioneering contributions to optogenetics, a technique that has transformed how researchers investigate the inner workings of the nervous system.
The Nobel committee announced the award in recognition of research that has helped scientists better understand how the human brain functions. In its citation, the committee praised the three laureates for laying the foundation of an entirely new era in neuroscience. Their discoveries, the committee said, have made it possible to reveal the neural circuits behind specific memories, feelings and behaviours that are relevant to neurological and psychiatric disorders.
Optogenetics combines optics and genetics to control the activity of individual nerve cells with unprecedented precision. The approach works by introducing light-sensitive proteins into neurons, allowing researchers to switch those cells on or off simply by shining light on them. This gives scientists the ability to test, in real time, which groups of brain cells drive particular behaviours or emotional states.
Karl Deisseroth, a psychiatrist and neurologist based in the United States, has been a leading figure in the field and is widely credited with helping to establish optogenetics as a mainstream research tool. His clinical background as a psychiatrist has informed his interest in understanding the biological roots of mental experiences, including feelings and emotions. His work has bridged the gap between laboratory neuroscience and questions about human behaviour and mental illness.
Peter Hegemann and Georg Nagel, both from Germany, contributed essential discoveries about light-sensitive proteins that made the technique possible. Their research identified and characterised microbial proteins known as channelrhodopsins, which respond to light by allowing ions to flow across cell membranes. This fundamental work provided the molecular tools that Deisseroth and others later adapted to control neurons in living animals.
The implications of this research extend far beyond basic science. By enabling researchers to map the circuits that underlie memory, emotion and behaviour, optogenetics has opened up new ways of thinking about conditions such as depression, anxiety, addiction and neurodegenerative disease. Scientists can now manipulate specific neural pathways and observe the results, offering clues about which circuits malfunction in psychiatric and neurological disorders.
The Nobel committee specifically highlighted the technique's role in uncovering the neural circuits behind memories, feelings and behaviours connected to these disorders. That phrasing reflects the growing hope that a deeper understanding of brain circuitry will eventually lead to more targeted treatments. Rather than treating symptoms broadly, future therapies could potentially address the precise neural pathways involved in a given condition.
The method is also being explored in clinical medicine, though such applications remain at an earlier stage. One promising avenue is the use of optogenetic techniques to try to restore sight in people with visual impairment. By introducing light-sensitive proteins into surviving retinal cells, researchers hope to bypass damaged photoreceptors and restore some degree of vision. This work builds directly on the same principles that earned the three laureates the prize.
The award recognises decades of collaboration and competition across continents. Deisseroth's laboratory in the United States and the German researchers' work on light-sensitive proteins converged to create a technique that neither group could have developed alone. The prize thus reflects the increasingly international and interdisciplinary nature of modern neuroscience, which draws on genetics, physics, engineering and medicine.
For the field of neuroscience, the recognition is significant because it validates a method that has become a standard part of the research toolkit. Optogenetics has spread to laboratories around the world, where it is used to study everything from learning and reward to sleep and social behaviour. Its rise illustrates how a clever combination of existing ideas can unlock entirely new lines of inquiry.
The prize also carries symbolic weight for psychiatry, a discipline that has often lagged behind other areas of medicine in understanding the biological basis of its conditions. By honouring a practising psychiatrist, the committee has drawn attention to the importance of bridging clinical care and fundamental research. Deisseroth's dual role as a clinician and scientist exemplifies that connection.
Announcements of the Nobel Prize in Physiology or Medicine traditionally open the annual Nobel season, with prizes in physics, chemistry and other fields to follow. The medicine prize is widely regarded as one of the most prestigious honours in science, and past winners have included many of the figures who shaped modern biology and medicine. This year's award places optogenetics alongside those landmark achievements.
In practical terms, the technique has changed how experiments are designed. Instead of merely observing brain activity, researchers can now intervene and test cause and effect. That shift from correlation to causation has been crucial in moving neuroscience beyond description toward genuine mechanistic explanation, a change that the Nobel committee explicitly acknowledged in its praise of the laureates.
Looking ahead, the three scientists' work is likely to keep shaping research for years. As tools become more refined and less invasive, the potential to study complex human emotions and disorders grows. The Nobel committee's decision underscores the value of basic discoveries that, over time, ripple outward into medicine, technology and our understanding of what makes us feel and behave as we do.
Comments (0)